Patents by Inventor Katerina Pokorna

Katerina Pokorna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200147191
    Abstract: Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.
    Type: Application
    Filed: December 30, 2019
    Publication date: May 14, 2020
    Inventors: Jitka Fucikova, Lenka Koci, Katerina Pokorna, Iva Truxova, Irena Moserova, Daniela Rozkova, Radek Spisek
  • Patent number: 10561717
    Abstract: Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: February 18, 2020
    Assignee: SOTIO a.s.
    Inventors: Jitka Fucikova, Lenka Koci, Katerina Pokorna, Iva Truxova, Irena Moserova, Daniela Rozkova, Radek Spisek
  • Publication number: 20190070278
    Abstract: Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.
    Type: Application
    Filed: November 2, 2018
    Publication date: March 7, 2019
    Inventors: Jitka Fucikova, Lenka Koci, Katerina Pokorna, Iva Truxova, Irena Moserova, Daniela Rozkova, Radek Spisek
  • Patent number: 10155033
    Abstract: Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: December 18, 2018
    Assignee: SOTIO A.S.
    Inventors: Jitka Fucikova, Lenka Koci, Katerina Pokorna, Iva Truxova, Irena Moserova, Daniela Rozkova, Radek Spisek
  • Publication number: 20180125956
    Abstract: Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.
    Type: Application
    Filed: January 10, 2018
    Publication date: May 10, 2018
    Inventors: Jitka Fucikova, Lenka Koci, Katerina Pokorna, Iva Truxova, Irena Moserova, Daniela Rozkova, Radek Spisek
  • Patent number: 9895430
    Abstract: Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: February 20, 2018
    Assignee: SOTIO A.S.
    Inventors: Jitka Fucikova, Lenka Koci, Katerina Pokorna, Iva Truxova, Irena Moserova, Daniela Rozkova, Radek Spisek
  • Publication number: 20170232086
    Abstract: Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.
    Type: Application
    Filed: December 22, 2016
    Publication date: August 17, 2017
    Inventors: Jitka Fucikova, Lenka Koci, Katerina Pokorna, Iva Truxova, Irena Moserova, Daniela Rozkova, Radek Spisek
  • Patent number: 9562219
    Abstract: Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: February 7, 2017
    Assignee: SOTIO A.S.
    Inventors: Jitka Fucikova, Lenka Koci, Katerina Pokorna, Iva Truxova, Irena Moserova, Daniela Rozkova, Radek Spisek
  • Publication number: 20150184130
    Abstract: Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.
    Type: Application
    Filed: December 27, 2013
    Publication date: July 2, 2015
    Applicant: SOTIO a.s.
    Inventors: Jitka Fucikova, Lenka Koci, Katerina Pokorna, Iva Truxova, Irena Moserova, Daniela Rozkova, Radek Spisek